About Alvion
Private. Independent. Global.
Our Story
Alvion is a science-oriented pharmaceutical company developing and manufacturing non infringing generics and value-added medicines in Europe.
Collaborating with state-of-the-art R&D centres in the EU, Alvion is a private and independent company focusing in R&D, IP, Quality, Regulatory and manufacturing of generic and added-value medicines — delivering an exceptional track record in the global pharmaceutical market, supplying millions of patients.
By developing a best-in-class international pharmaceutical company, Alvion is launching a wide portfolio of products and services across Europe, MENA, Canada, Australia, South Africa and Latin America, and soon to USA — partnering with some of the most well-known multinational pharmaceutical companies.
Operating from Athens, Greece, Alvion Group is an Intellectual Property powerhouse offering non infringing medicines and high-level services to more than ninety pharmaceutical companies on a B2B basis.
Out-licensing its proprietary portfolio and supplying these medicines to partners worldwide form the core of the Group’s business model, supporting its ambition to become one of Europe’s leading pharmaceutical companies.
Partner with AlvionDeveloping in high technology intellectual properties — often patented technologies — providing licensing rights to the largest pharmaceutical companies in the world.
Focusing on delivering innovation and best quality pharmaceuticals among the first companies prior to patent expiry, while offering flexible terms and affordable medicines with an effective supply chain.
Alvion adheres to the highest standards of manufacturing and regulatory compliance, ensuring all products meet the stringent requirements set forth by regulatory authorities worldwide.
Welcoming business opportunities with multinational and strong local pharmaceutical companies via licensing agreements — both proprietary and supply — delivering complete packages at all stages.
Our Purpose
A science pharmaceutical company offering difficult to develop and non infringing products to its partners, setting a new standard in generics by combining our experiences with an understanding of healthcare needs at a global level.
A diversified business model that enriches quality of life and delivers outstanding value to all stakeholders — from patients and healthcare providers to our partners, investors and communities.
To become a leading and vertically integrated pharmaceutical company, establishing a global presence, serving the healthcare communities and satisfying high-performance employees around the world.
Geographic Reach
At Alvion, we are rethinking pharmaceuticals with a new business model that creates the pharmaceutical company of tomorrow. We strive for a change that is clearly visible in the various pharmaceutical markets, our model, processes and actions.
Through its global reach from its headquarters in Athens, Greece, the group is marketing a wide range of complex products via marketing leaders across fifty-plus markets, targeting always to be first to market.
Ethics & Conduct
Alvion is committed to fair and vigorous competition because this is essential to ensure an appropriate and fair market and, even more so, to ensure full access to affordable healthcare.
Alvion does not tolerate any breach or possible infringement of any competition laws and regulations in any of its businesses worldwide.
Get in touchRegulatory Compliance: Adhering to the highest standards of manufacturing and regulatory compliance in all markets where we operate.
Non-Infringing Practices: All Alvion products are developed as non infringing, respecting intellectual property rights across all jurisdictions.
Fair Competition: We compete vigorously but fairly, and we will not engage in anticompetitive conduct under any circumstances.
Transparent Governance: Ethical and transparent corporate governance at every level of the organization, guided by ESG principles.
Affordable Access: A commitment to ensuring full access to affordable healthcare remains central to every business decision we make.
Ready to Collaborate?
Contact our Business Development Department to discuss licensing, supply, co-development and regulatory collaboration.
Contact Business Development